Published in Compr Psychiatry on January 13, 2003
A validation study of the Korean version of SPAN. Yonsei Med J (2011) 0.83
The psychological effect of severe acute respiratory syndrome on emergency department staff. Emerg Med J (2007) 0.83
Validation of the Davidson Trauma Scale in its original and a new shorter version in people exposed to the F-27 earthquake in Chile. Eur J Psychotraumatol (2013) 0.82
Comparing screening instruments to predict posttraumatic stress disorder. PLoS One (2014) 0.81
Psychometric validation of the Korean version of Structured Interview for Post-traumatic Stress Disorder (K-SIP). J Korean Med Sci (2009) 0.75
Variant GADL1 and response to lithium therapy in bipolar I disorder. N Engl J Med (2013) 5.71
Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol (2003) 1.84
Effectiveness of a work-related stress management program in patients with chronic schizophrenia. Am J Occup Ther (2006) 1.45
Venlafaxine-induced excessive yawning. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.43
History of the discovery and clinical introduction of chlorpromazine. Ann Clin Psychiatry (2006) 1.31
Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study. J Clin Psychiatry (2013) 1.12
Cabergoline-induced psychotic exacerbation in schizophrenic patients. Gen Hosp Psychiatry (2008) 1.10
Long-term psychological outcome of 1999 Taiwan earthquake survivors: a survey of a high-risk sample with property damage. Compr Psychiatry (2007) 1.07
Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol (2003) 1.05
Immunologic variables in acute mania of bipolar disorder. J Neuroimmunol (2004) 1.02
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment. Pharmacogenet Genomics (2011) 1.00
Surgical adverse outcomes in patients with schizophrenia: a population-based study. Ann Surg (2013) 0.98
CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer. J Clin Psychopharmacol (2011) 0.97
Posttraumatic stress disorder among professional and non-professional rescuers involved in an earthquake in Taiwan. Psychiatry Res (2004) 0.96
Implication of serum concentration monitoring in patients with lithium intoxication. Psychiatry Clin Neurosci (2004) 0.95
Serotonin syndrome induced by low-dose venlafaxine. Ann Pharmacother (2003) 0.94
Sleep-related eating disorder induced by risperidone. J Clin Psychiatry (2004) 0.94
Suicide and unemployment rate in Taiwan, a population-based study, 1978-2006. Soc Psychiatry Psychiatr Epidemiol (2009) 0.91
Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol Alcohol (2008) 0.91
Psychiatric disorders after epilepsy diagnosis: a population-based retrospective cohort study. PLoS One (2013) 0.91
PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites. J Clin Psychopharmacol (2013) 0.89
Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome. Schizophr Res (2004) 0.89
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response. Pharmacogenomics (2010) 0.88
Modulation of the development of human monocyte-derived dendritic cells by lithium chloride. J Cell Physiol (2011) 0.85
Prevalence and identification of alcohol use disorders among severe mental illness inpatients in Taiwan. Psychiatry Clin Neurosci (2009) 0.84
Somnambulism secondary to olanzapine treatment in one patient with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.84
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine. Pharmacogenomics (2010) 0.84
Omega-3 fatty acids for depression in pregnancy. Am J Psychiatry (2003) 0.84
UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients. Pharmacogenomics (2012) 0.83
Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.83
Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.83
ECT generalized seizure drives heart rate above treadmill stress test maximum. J ECT (2007) 0.83
Screening postpartum depression with the Taiwanese version of the Edinburgh Postnatal Depression scale. Compr Psychiatry (2005) 0.83
The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.83
High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. Addict Behav (2013) 0.82
Health-seeking behavior, alternative medicine, and quality of life in Taiwanese panic disorder patients. Int J Psychiatry Clin Pract (2012) 0.82
Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.82
Paliperidone-induced mania-like symptoms: a case report. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.81
Worsening psychosis after adding aripiprazole to clozapine. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.81
Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort. OMICS (2013) 0.81
The early effect of olanzapine and risperidone on insulin secretion in atypical-naïve schizophrenic patients. J Clin Psychopharmacol (2006) 0.81
Trends in scientific literature on atypical antipsychotics in South Korea: a bibliometric study. Psychiatry Investig (2013) 0.81
Gender differences in the effects of peroxisome proliferator-activated receptor γ2 gene polymorphisms on metabolic adversity in patients with schizophrenia or schizoaffective disorder. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.81
Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission. J Affect Disord (2002) 0.81
Use of low-dose topiramate in substance use disorder and bodyweight control. Psychiatry Clin Neurosci (2007) 0.81
Trends, correlates, and disease patterns of antipsychotic use among children and adolescents in Taiwan. Soc Psychiatry Psychiatr Epidemiol (2013) 0.80
Alcohol use problem among patients in methadone maintenance treatment in Taiwan. J Subst Abuse Treat (2010) 0.80
Screening and confirmation of 62 drugs of abuse and metabolites in urine by ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. J Anal Toxicol (2013) 0.80
Age, gender, depression, and sexual dysfunction in Taiwan. J Sex Med (2009) 0.79
Metoclopramide-induced supersensitivity psychosis. Ann Pharmacother (2002) 0.79
Associations between n-3 PUFA concentrations and cognitive function after recovery from late-life depression. Am J Clin Nutr (2012) 0.79
Prevalence of psychiatric disorders among heroin users who received methadone maintenance therapy in Taiwan. Am J Addict (2014) 0.79
Taiwan consensus of pharmacological treatment for bipolar disorder. J Chin Med Assoc (2013) 0.79
Pityriasis rosea-like eruption associated with clozapine: a case report. Gen Hosp Psychiatry (2012) 0.79
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions. Pharmacogenomics (2013) 0.78
Ovarian cancer and antidepressants. Psychooncology (2014) 0.78
A multilevel analysis of regional and individual effects on methadone maintenance treatment in Taiwan. Value Health (2012) 0.78
A pilot cross-over design study on QTc interval prolongation associated with sulpiride and haloperidol. Schizophr Res (2003) 0.78
Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease. Psychiatry Clin Neurosci (2012) 0.78
Associations of polyunsaturated fatty acids with residual depression or anxiety in older people with major depression. J Affect Disord (2011) 0.78
Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia. J Clin Pharmacol (2004) 0.78
Trends, correlates, and disease patterns of antidepressant use among children and adolescents in Taiwan. J Child Neurol (2012) 0.77
Aripiprazole resolves symptomatic hyperprolactinemia in a male schizophrenic patient. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.77
Mapping the scientific research on atypical antipsychotic drugs in Spain: a bibliometric assessment. Actas Esp Psiquiatr (2013) 0.76
Serum lipid profile could predict the inception and impacts of violent behaviors among acute psychiatric inpatients. Chang Gung Med J (2012) 0.76
Application of the Cockcroft-Gault method to estimate lithium dosage requirement. Psychiatry Clin Neurosci (2007) 0.76
Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients. J Clin Psychopharmacol (2007) 0.76
Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine. Psychiatry Clin Neurosci (2009) 0.76
Weight gain and ghrelin level after olanzapine monotherapy. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.76
The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder. J Clin Psychopharmacol (2012) 0.76
The Relationships of Obesity-Related Genetic Variants With Metabolic Profiles and Response to Metformin in Clozapine-Treated Patients With Schizophrenia. J Clin Psychopharmacol (2015) 0.76
Comment: risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Ann Pharmacother (2002) 0.75
Prolongation of QTc interval and antipsychotics. Am J Psychiatry (2002) 0.75
Estimation of lithium dose requirement by body weight. Bipolar Disord (2002) 0.75
Comments on article by Albers et al: "Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy". J Clin Psychopharmacol (2005) 0.75
A social skills training program for preschool children with attention-deficit/hyperactivity disorder. Chang Gung Med J (2004) 0.75
A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.75
Heavy smoking, reduced olanzapine levels, and treatment effects: a case report. Ther Drug Monit (2004) 0.75
Fluvoxamine-clozapine interaction: time-dependent? J Clin Psychopharmacol (2002) 0.75
Dosing strategies of clozapine-fluvoxamine cotreatment. J Clin Psychopharmacol (2002) 0.75
The use of alternative medicine among Taiwanese psychiatric outpatients. Psychiatry Clin Neurosci (2005) 0.75
Use of carbamazepine and lamotrigine in a Taiwanese diabetic patient with bipolar disorder. Psychiatry Clin Neurosci (2012) 0.75
Validity and reliability of the Chinese version of the Sheehan Disability Scale (SDS-C). Asia Pac Psychiatry (2015) 0.75
Combined therapy with thioridazine decreases plasma levels of quetiapine inTaiwanese schizophrenic patients. Ther Drug Monit (2012) 0.75
Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.75
The genetic association of FTO variants with metabolic traits in patients with schizophrenia may be modified by antipsychotics. J Clin Psychopharmacol (2014) 0.75